Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

The Relationship Between the Sexual Self and the Experience of Pregnancy.

Lund JI, Kleinplatz PJ, Charest M, Huber JD.

J Perinat Educ. 2019 Jan 1;28(1):43-50. doi: 10.1891/1058-1243.28.1.43.

PMID:
31086474
2.

Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes.

Hernandez A, Tan C, Plattner F, Logsdon AF, Pozo K, Yousuf MA, Singh T, Turner RC, Luke-Wold BP, Huber JD, Rosen CL, Bibb JA.

Mol Brain. 2018 Nov 9;11(1):64. doi: 10.1186/s13041-018-0408-1.

3.

Reduction of Endothelial Nitric Oxide Increases the Adhesiveness of Constitutive Endothelial Membrane ICAM-1 through Src-Mediated Phosphorylation.

Gao F, Lucke-Wold BP, Li X, Logsdon AF, Xu LC, Xu S, LaPenna KB, Wang H, Talukder MAH, Siedlecki CA, Huber JD, Rosen CL, He P.

Front Physiol. 2018 Jan 10;8:1124. doi: 10.3389/fphys.2017.01124. eCollection 2017.

4.

Discovery and optimization of oxadiazole-based FLAP inhibitors.

Bartolozzi A, Abeywardane A, Bosanac T, Broadwater JA, Chen Z, Hutzler JM, Huber JD, Nemoto P, Olague A, Riether D, Simpson T, Takahashi H, Wu L, Zhang Y, Zindell RM.

Bioorg Med Chem Lett. 2017 Oct 15;27(20):4652-4659. doi: 10.1016/j.bmcl.2017.09.007. Epub 2017 Sep 8.

PMID:
28927794
5.

A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior.

Logsdon AF, Lucke-Wold BP, Turner RC, Li X, Adkins CE, Mohammad AS, Huber JD, Rosen CL, Lockman PR.

Arch Neurosci. 2017 Apr;4(2). pii: e44254. Epub 2017 Apr 30.

6.

The role for infarct volume as a surrogate measure of functional outcome following ischemic stroke.

Turner RC, DiPasquale K, Logsdon AF, Tan Z, Naser ZJ, Huber JD, Rosen CL, Lucke-Wold BP.

J Syst Integr Neurosci. 2016 Dec;2(4). doi: 10.15761/JSIN.1000136. Epub 2016 Oct 11.

7.

Single low-dose lipopolysaccharide preconditioning: neuroprotective against axonal injury and modulates glial cells.

Turner RC, Naser ZJ, Lucke-Wold BP, Logsdon AF, Vangilder RL, Matsumoto RR, Huber JD, Rosen CL.

Neuroimmunol Neuroinflamm. 2017 Jan;4:6-15. doi: 10.20517/2347-8659.2016.40. Epub 2017 Jan 20.

8.

Endoplasmic Reticulum Stress Modulation as a Target for Ameliorating Effects of Blast Induced Traumatic Brain Injury.

Lucke-Wold BP, Logsdon AF, Turner RC, Huber JD, Rosen CL.

J Neurotrauma. 2017 Sep;34(S1):S62-S70. doi: 10.1089/neu.2016.4680. Epub 2017 Feb 27.

9.

Elucidating the role of compression waves and impact duration for generating mild traumatic brain injury in rats.

Lucke-Wold BP, Phillips M, Turner RC, Logsdon AF, Smith KE, Huber JD, Rosen CL, Regele JD.

Brain Inj. 2017;31(1):98-105. doi: 10.1080/02699052.2016.1218547. Epub 2016 Nov 23.

10.

Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice.

Nguyen L, Lucke-Wold BP, Logsdon AF, Scandinaro AL, Huber JD, Matsumoto RR.

Neuroreport. 2016 Sep 28;27(14):1004-11. doi: 10.1097/WNR.0000000000000646.

11.

Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury.

Logsdon AF, Lucke-Wold BP, Nguyen L, Matsumoto RR, Turner RC, Rosen CL, Huber JD.

Brain Res. 2016 Jul 15;1643:140-51. doi: 10.1016/j.brainres.2016.04.063. Epub 2016 Apr 27.

12.

Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review.

Lucke-Wold BP, Logsdon AF, Manoranjan B, Turner RC, McConnell E, Vates GE, Huber JD, Rosen CL, Simard JM.

Int J Mol Sci. 2016 Apr 2;17(4):497. doi: 10.3390/ijms17040497. Review.

13.

Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery.

Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Lee JM, Bailes JE, Dashnaw ML, Huber JD, Petraglia AL, Rosen CL.

Front Neurol. 2015 Oct 26;6:223. doi: 10.3389/fneur.2015.00223. eCollection 2015. Review.

14.

The Quest to Model Chronic Traumatic Encephalopathy: A Multiple Model and Injury Paradigm Experience.

Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Dashnaw ML, Huang JH, Smith KE, Huber JD, Rosen CL, Petraglia AL.

Front Neurol. 2015 Oct 20;6:222. doi: 10.3389/fneur.2015.00222. eCollection 2015.

15.

Traumatic brain injury and epilepsy: Underlying mechanisms leading to seizure.

Lucke-Wold BP, Nguyen L, Turner RC, Logsdon AF, Chen YW, Smith KE, Huber JD, Matsumoto R, Rosen CL, Tucker ES, Richter E.

Seizure. 2015 Dec;33:13-23. doi: 10.1016/j.seizure.2015.10.002. Epub 2015 Oct 29. Review.

16.

Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury.

Lucke-Wold BP, Naser ZJ, Logsdon AF, Turner RC, Smith KE, Robson MJ, Bailes JE, Lee JM, Rosen CL, Huber JD.

Transl Res. 2015 Dec;166(6):509-528.e1. doi: 10.1016/j.trsl.2015.08.005. Epub 2015 Sep 8.

PMID:
26414010
17.

Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy.

Lucke-Wold BP, Turner RC, Logsdon AF, Nguyen L, Bailes JE, Lee JM, Robson MJ, Omalu BI, Huber JD, Rosen CL.

J Neurosurg. 2016 Mar;124(3):687-702. doi: 10.3171/2015.3.JNS141802. Epub 2015 Sep 18.

PMID:
26381255
18.

Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.

Tan Z, Lucke-Wold BP, Logsdon AF, Turner RC, Tan C, Li X, Hongpaison J, Alkon DL, Simpkins JW, Rosen CL, Huber JD.

Eur J Pharmacol. 2015 Oct 5;764:404-12. doi: 10.1016/j.ejphar.2015.07.035. Epub 2015 Jul 17.

19.

Role of Microvascular Disruption in Brain Damage from Traumatic Brain Injury.

Logsdon AF, Lucke-Wold BP, Turner RC, Huber JD, Rosen CL, Simpkins JW.

Compr Physiol. 2015 Jul 1;5(3):1147-60. doi: 10.1002/cphy.c140057. Review.

20.

Sleep disruption and the sequelae associated with traumatic brain injury.

Lucke-Wold BP, Smith KE, Nguyen L, Turner RC, Logsdon AF, Jackson GJ, Huber JD, Rosen CL, Miller DB.

Neurosci Biobehav Rev. 2015 Aug;55:68-77. doi: 10.1016/j.neubiorev.2015.04.010. Epub 2015 May 6. Review.

21.

Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms.

Logsdon AF, Turner RC, Lucke-Wold BP, Robson MJ, Naser ZJ, Smith KE, Matsumoto RR, Huber JD, Rosen CL.

Front Cell Neurosci. 2014 Dec 10;8:421. doi: 10.3389/fncel.2014.00421. eCollection 2014.

22.

Aging, the metabolic syndrome, and ischemic stroke: redefining the approach for studying the blood-brain barrier in a complex neurological disease.

Lucke-Wold BP, Logsdon AF, Turner RC, Rosen CL, Huber JD.

Adv Pharmacol. 2014;71:411-49. doi: 10.1016/bs.apha.2014.07.001. Epub 2014 Sep 12. Review.

PMID:
25307225
23.

Bryostatin-1 Restores Blood Brain Barrier Integrity following Blast-Induced Traumatic Brain Injury.

Lucke-Wold BP, Logsdon AF, Smith KE, Turner RC, Alkon DL, Tan Z, Naser ZJ, Knotts CM, Huber JD, Rosen CL.

Mol Neurobiol. 2015 Dec;52(3):1119-1134. doi: 10.1007/s12035-014-8902-7. Epub 2014 Oct 10.

24.

Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration.

Lucke-Wold BP, Turner RC, Logsdon AF, Simpkins JW, Alkon DL, Smith KE, Chen YW, Tan Z, Huber JD, Rosen CL.

J Alzheimers Dis. 2015;43(3):711-24. doi: 10.3233/JAD-141422. Review.

25.
26.

Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.

Tan Z, Li X, Turner RC, Logsdon AF, Lucke-Wold B, DiPasquale K, Jeong SS, Chen R, Huber JD, Rosen CL.

Eur J Pharmacol. 2014 Sep 5;738:368-73. doi: 10.1016/j.ejphar.2014.05.052. Epub 2014 Jun 13.

27.

Ischemic stroke injury is mediated by aberrant Cdk5.

Meyer DA, Torres-Altoro MI, Tan Z, Tozzi A, Di Filippo M, DiNapoli V, Plattner F, Kansy JW, Benkovic SA, Huber JD, Miller DB, Greengard P, Calabresi P, Rosen CL, Bibb JA.

J Neurosci. 2014 Jun 11;34(24):8259-67. doi: 10.1523/JNEUROSCI.4368-13.2014.

28.

A high-throughput scintillation proximity assay for sphingosine-1-phosphate lyase.

Kashem MA, Wa C, Wolak JP, Grafos NS, Ryan KR, Sanville-Ross ML, Fogarty KE, Rybina IV, Shoultz A, Molinaro T, Desai SN, Rajan A, Huber JD, Nelson RM.

Assay Drug Dev Technol. 2014 Jun;12(5):293-302. doi: 10.1089/adt.2014.575. Epub 2014 May 20.

PMID:
24846303
29.

Disparity among neural injury models and the unfolded protein response.

Logsdon AF, Lucke-Wold BP, Rosen CL, Huber JD.

J Neurol Disord Stroke. 2014 May-Jun;2(3). pii: 1074. Epub 2014 Feb 21.

30.

Metabolic Syndrome and its Profound Effect on Prevalence of Ischemic Stroke.

Lucke-Wold BP, DiPasquale K, Logsdon AF, Nguyen L, Lucke-Wold AN, Turner RC, Huber JD, Rosen CL.

Am Med Stud Res J. 2014 Spring;1(1):29-38.

31.

SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.

Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O'Callaghan JP, Huber JD, Matsumoto RR.

Exp Neurol. 2014 Apr;254:180-9. doi: 10.1016/j.expneurol.2014.01.020. Epub 2014 Feb 6.

32.

Linking traumatic brain injury to chronic traumatic encephalopathy: identification of potential mechanisms leading to neurofibrillary tangle development.

Lucke-Wold BP, Turner RC, Logsdon AF, Bailes JE, Huber JD, Rosen CL.

J Neurotrauma. 2014 Jul 1;31(13):1129-38. doi: 10.1089/neu.2013.3303. Epub 2014 Apr 11. Review.

33.

Elucidating the severity of preclinical traumatic brain injury models: a role for functional assessment?

Turner RC, VanGilder RL, Naser ZJ, Lucke-Wold BP, Bailes JE, Matsumoto RR, Huber JD, Rosen CL.

Neurosurgery. 2014 Apr;74(4):382-94; discussion 394. doi: 10.1227/NEU.0000000000000292.

34.

A review of sleep deprivation studies evaluating the brain transcriptome.

Elliott AS, Huber JD, O'Callaghan JP, Rosen CL, Miller DB.

Springerplus. 2014 Dec 11;3:728. doi: 10.1186/2193-1801-3-728. eCollection 2014. Review.

35.

C-reactive protein and long-term ischemic stroke prognosis.

VanGilder RL, Davidov DM, Stinehart KR, Huber JD, Turner RC, Wilson KS, Haney E, Davis SM, Chantler PD, Theeke L, Rosen CL, Crocco TJ, Gutmann L, Barr TL.

J Clin Neurosci. 2014 Apr;21(4):547-53. doi: 10.1016/j.jocn.2013.06.015. Epub 2013 Aug 23. Review.

36.

Bryostatin improves survival and reduces ischemic brain injury in aged rats after acute ischemic stroke.

Tan Z, Turner RC, Leon RL, Li X, Hongpaisan J, Zheng W, Logsdon AF, Naser ZJ, Alkon DL, Rosen CL, Huber JD.

Stroke. 2013 Dec;44(12):3490-7. doi: 10.1161/STROKEAHA.113.002411. Epub 2013 Oct 30.

37.

Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats.

Turner RC, Naser ZJ, Logsdon AF, DiPasquale KH, Jackson GJ, Robson MJ, Gettens RT, Matsumoto RR, Huber JD, Rosen CL.

Exp Neurol. 2013 Oct;248:520-9. doi: 10.1016/j.expneurol.2013.07.008. Epub 2013 Jul 20.

PMID:
23876514
38.

SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation.

Robson MJ, Turner RC, Naser ZJ, McCurdy CR, Huber JD, Matsumoto RR.

Exp Neurol. 2013 Sep;247:134-42. doi: 10.1016/j.expneurol.2013.04.009. Epub 2013 Apr 28.

39.

Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions.

Turner RC, Lucke-Wold B, Lucke-Wold N, Elliott AS, Logsdon AF, Rosen CL, Huber JD.

Int J Mol Sci. 2013 Jan 17;14(1):1890-917. doi: 10.3390/ijms14011890. Review.

40.

The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success.

Turner RC, Dodson SC, Rosen CL, Huber JD.

J Neurosurg. 2013 May;118(5):1072-85. doi: 10.3171/2012.11.JNS12408. Epub 2013 Jan 18. Review.

41.

Age and the metabolic syndrome as risk factors for ischemic stroke: improving preclinical models of ischemic stroke.

Lucke-Wold BP, Turner RC, Lucke-Wold AN, Rosen CL, Huber JD.

Yale J Biol Med. 2012 Dec;85(4):523-39. Epub 2012 Dec 13. Review.

42.

Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat.

Huber JD, Bentzien J, Boyer SJ, Burke J, De Lombaert S, Eickmeier C, Guo X, Haist JV, Hickey ER, Kaplita P, Karmazyn M, Kemper R, Kennedy CA, Kirrane T, Madwed JB, Mainolfi E, Nagaraja N, Soleymanzadeh F, Swinamer A, Eldrup AB.

J Med Chem. 2012 Aug 23;55(16):7114-40. doi: 10.1021/jm300601d. Epub 2012 Aug 6.

PMID:
22803959
43.

Effects of aging on behavioral assessment performance: implications for clinically relevant models of neurological disease.

Turner RC, Seminerio MJ, Naser ZJ, Ford JN, Martin SJ, Matsumoto RR, Rosen CL, Huber JD.

J Neurosurg. 2012 Sep;117(3):629-37. doi: 10.3171/2012.5.JNS112224. Epub 2012 Jun 29.

PMID:
22746378
44.

Worsened outcome from middle cerebral artery occlusion in aged rats receiving 17β-estradiol.

Leon RL, Li X, Huber JD, Rosen CL.

Endocrinology. 2012 Jul;153(7):3386-93. doi: 10.1210/en.2011-1859. Epub 2012 May 11.

45.

The transcriptome of cerebral ischemia.

VanGilder RL, Huber JD, Rosen CL, Barr TL.

Brain Res Bull. 2012 Jul 1;88(4):313-9. doi: 10.1016/j.brainresbull.2012.02.002. Epub 2012 Feb 21. Review.

46.

Potential age-dependent effects of estrogen on neural injury.

Leon RL, Huber JD, Rosen CL.

Am J Pathol. 2011 Jun;178(6):2450-60. doi: 10.1016/j.ajpath.2011.01.057. Review.

47.

Targeting the neurovascular unit for treatment of neurological disorders.

Vangilder RL, Rosen CL, Barr TL, Huber JD.

Pharmacol Ther. 2011 Jun;130(3):239-47. doi: 10.1016/j.pharmthera.2010.12.004. Epub 2010 Dec 21. Review.

48.

Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.

Seminerio MJ, Kaushal N, Shaikh J, Huber JD, Coop A, Matsumoto RR.

Pharmacol Biochem Behav. 2011 Mar;98(1):12-20. doi: 10.1016/j.pbb.2010.11.023. Epub 2010 Dec 2.

49.

Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat.

Dinapoli VA, Benkovic SA, Li X, Kelly KA, Miller DB, Rosen CL, Huber JD, O'Callaghan JP.

Neuroscience. 2010 Oct 13;170(2):633-44. doi: 10.1016/j.neuroscience.2010.07.011. Epub 2010 Jul 13.

50.

NOX2 inhibition with apocynin worsens stroke outcome in aged rats.

Kelly KA, Li X, Tan Z, VanGilder RL, Rosen CL, Huber JD.

Brain Res. 2009 Oct 6;1292:165-72. doi: 10.1016/j.brainres.2009.07.052. Epub 2009 Jul 25.

Supplemental Content

Loading ...
Support Center